Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah Watson

Showing results (211-220 of 240) with videos related to

Pageof 24
Sort By:
Medrxiv : the Preprint Server for Health Sciences|July 1, 2024
Multi-ancestry Genome-Wide Association Meta-Analysis Identifies Novel Loci in Atopic DermatitisMeritxell Oliva, Mrinal K Sarkar, Michael E March, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 24, 2024
Novel insights into the phenotypic spectrum and pathogenesis of Hardikar syndromeAlanna Strong, Michael E March, Christopher J Cardinale, et al.
The Lancet. Global Health|September 16, 2022
Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label, randomised, non-inferiority trialDeborah Watson-Jones, John Changalucha, Hilary Whitworth, et al.
Lancet (London, England)|August 15, 2018
Prevention of Ebola virus disease through vaccination: where we are in 2018Yves Lévy, Clifford Lane, Peter Piot, et al.
Plos Neglected Tropical Diseases|January 30, 2026
Effect of the time of day for vaccination on the immune response to Ebola Virus Disease vaccines: A modeling study from PREVAC randomized trialAnge-Marie D Kpetigo, Marie Alexandre, Aboubacar Camara, et al.
Plos Medicine|March 2, 2011
Intravaginal practices, bacterial vaginosis, and HIV infection in women: individual participant data meta-analysisNicola Low, Matthew F Chersich, Kurt Schmidlin, et al.
Vaccine|June 30, 2026
Effect of malaria parasitaemia on antibody responses to single-dose and two-dose HPV vaccination: results from the DoRIS dose-reduction immunogenicity trial in Tanzanian girlsHilary S Whitworth, Khalid B Beshir, Kathy J Baisley, et al.
The Lancet. Global Health|January 31, 2025
Durability of immunogenicity at 5 years after a single dose of human papillomavirus vaccine compared with two doses in Tanzanian girls aged 9-14 years: results of the long-term extension of the DoRIS randomised trialDeborah Watson-Jones, John Changalucha, Caroline Maxwell, et al.
Emerging Infectious Diseases|February 24, 2022
Ebola Virus Glycoprotein IgG Seroprevalence in Community Previously Affected by Ebola, Sierra LeoneDaniela Manno, Philip Ayieko, David Ishola, et al.
Nature Communications|March 31, 2025
Integration of GWAS, QTLs and keratinocyte functional assays reveals molecular mechanisms of atopic dermatitisMeritxell Oliva, Mrinal K Sarkar, Michael E March, et al.
Pageof 24

Showing results (211-220 of 240) with videos related to

Sort By:
Pageof 24
Medrxiv : the Preprint Server for Health Sciences|July 1, 2024
Multi-ancestry Genome-Wide Association Meta-Analysis Identifies Novel Loci in Atopic DermatitisMeritxell Oliva, Mrinal K Sarkar, Michael E March, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 24, 2024
Novel insights into the phenotypic spectrum and pathogenesis of Hardikar syndromeAlanna Strong, Michael E March, Christopher J Cardinale, et al.
The Lancet. Global Health|September 16, 2022
Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label, randomised, non-inferiority trialDeborah Watson-Jones, John Changalucha, Hilary Whitworth, et al.
Lancet (London, England)|August 15, 2018
Prevention of Ebola virus disease through vaccination: where we are in 2018Yves Lévy, Clifford Lane, Peter Piot, et al.
Plos Neglected Tropical Diseases|January 30, 2026
Effect of the time of day for vaccination on the immune response to Ebola Virus Disease vaccines: A modeling study from PREVAC randomized trialAnge-Marie D Kpetigo, Marie Alexandre, Aboubacar Camara, et al.
Plos Medicine|March 2, 2011
Intravaginal practices, bacterial vaginosis, and HIV infection in women: individual participant data meta-analysisNicola Low, Matthew F Chersich, Kurt Schmidlin, et al.
Vaccine|June 30, 2026
Effect of malaria parasitaemia on antibody responses to single-dose and two-dose HPV vaccination: results from the DoRIS dose-reduction immunogenicity trial in Tanzanian girlsHilary S Whitworth, Khalid B Beshir, Kathy J Baisley, et al.
The Lancet. Global Health|January 31, 2025
Durability of immunogenicity at 5 years after a single dose of human papillomavirus vaccine compared with two doses in Tanzanian girls aged 9-14 years: results of the long-term extension of the DoRIS randomised trialDeborah Watson-Jones, John Changalucha, Caroline Maxwell, et al.
Emerging Infectious Diseases|February 24, 2022
Ebola Virus Glycoprotein IgG Seroprevalence in Community Previously Affected by Ebola, Sierra LeoneDaniela Manno, Philip Ayieko, David Ishola, et al.
Nature Communications|March 31, 2025
Integration of GWAS, QTLs and keratinocyte functional assays reveals molecular mechanisms of atopic dermatitisMeritxell Oliva, Mrinal K Sarkar, Michael E March, et al.
Pageof 24